Cleerly Heart Scans Secured Medicare Coverage for Patients
Cleerly Heart Scans Secured Medicare Coverage for Patients
Recent developments in healthcare technology have led to exciting advancements in heart disease diagnostics. Several Medicare Administrative Contractors (MACs) have now approved the use of Artificial Intelligence-enabled Quantitative Coronary Topography (AI-QCT) scans for Medicare recipients. This exciting decision opens new doors for patients exhibiting symptoms suspicious of coronary artery disease.
AI-QCT Scans: A Cutting-Edge Solution
Cleerly, a company dedicated to revolutionizing cardiac health, has successfully advocated for this crucial development to ensure Medicare recipients have access to essential heart scans. The decision to expand coverage was officially requested in early 2023, reflecting Cleerly's ongoing commitment to providing advanced diagnostic solutions aimed at preventing heart attacks.
This significant coverage decision will come into full effect on November 24, 2024, across various administrative groups, including Palmetto GBA, CGS Administrators, National Government Services (NGS), and WPS. Essentially, this means that around 34 million Medicare beneficiaries in the U.S. will potentially benefit from this enhanced coverage.
Comprehensive Assessment with Cleerly Labs
Cleerly's AI-QCT technology, known as Cleerly Labs, is designed to deliver a thorough assessment of coronary artery disease through noninvasive Cardiac Computed Tomography Angiography (CCTA). This technology has remarkably demonstrated its accuracy in identifying the presence, extent, and composition of coronary atherosclerotic plaque, comparable to consensus readings by experienced physicians. Under the new Medicare coverage, Cleerly Labs will provide essential Plaque Analysis for patients presenting acute or stable chest pain, even if they have no known coronary artery disease (CAD).
Advancing Cardiac Care for At-Risk Patients
James K. Min, MD, the Founder and CEO of Cleerly, expressed his satisfaction with the decision made by the MACs. He emphasized the importance of ensuring that those at risk of heart events have access to the most advanced cardiovascular testing technology. The approval is a testament to the collective efforts of physicians and medical societies that advocated for this life-saving technology. Until now, healthcare providers struggled to assess the primary causes of heart attacks and evaluate a patient’s atherosclerotic plaque burden comprehensively. This new coverage marks a pivotal moment in the field of cardiology, supporting improved care pathways for the senior population.
Accessing Cleerly Heart Scans
For individuals interested in requesting a Cleerly scan, directions are available on Cleerly's website, which provides resources for finding nearby scan locations. This initiative significantly simplifies the process for those in need of cardiac assessment, ensuring that they can benefit from this following key advancement in cardiac health technology.
About Cleerly
Cleerly stands at the forefront of cardiac health innovation, committed to eliminating heart attacks and establishing new standards of care for heart disease. With FDA-cleared solutions powered by artificial intelligence, Cleerly facilitates a comprehensive understanding of coronary artery disease through advanced non-invasive imaging techniques. The company bases its methods on extensive scientific research, pulling insights from millions of images taken from over 40,000 patients.
Led by a distinguished team of clinical and technical experts, Cleerly prioritizes health literacy among all stakeholders involved in the cardiovascular care pathway, ensuring that each patient receives the best possible guidance for managing their heart health. Those seeking further information about Cleerly's mission and services are encouraged to visit their official website.
Frequently Asked Questions
What are AI-QCT scans?
AI-QCT scans are advanced diagnostic tools that use artificial intelligence to assess coronary artery disease noninvasively.
Who will benefit from the new Medicare coverage?
The new Medicare coverage will benefit approximately 34 million Medicare recipients at risk for heart disease.
When will the new coverage take effect?
The coverage will come into effect on November 24, 2024.
What is Cleerly's mission?
Cleerly aims to eliminate heart attacks by providing advanced diagnostic solutions and care standards for heart disease.
How can one request a Cleerly scan?
Individuals can request a Cleerly scan by visiting the Cleerly website for more information on nearby locations.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Expert Financial Recovery Counseling for Disaster Survivors
- Stainless Steel Flatware Market Set for Growth, Reaching $9.46B
- HASC to Exclusively Implement Safety Essentials for Training
- Sovrn Launches Innovative Ad Management Software for Publishers
- Understanding Class Action Legal Rights for Investors in EXTR
- Applied Software Partners with MSUITE for Enhanced Solutions
- WonderTree's Grand Opening: A New Era for Mental Health Care
- SoFi Technologies Partners with Fortress for Loan Growth
- How a Whale Trader Transformed a Huge Loss into Gains in Crypto
- Challenges Ahead for European Gas Supply as Winter Approaches
Recent Articles
- Descartes Strengthens Ecommerce Suite with Sellercloud Deal
- Warren Buffett's Top Dividend Stocks: Amazing Yields Revealed
- Empowering Cybersecurity: The Urgent Call for MFA Adoption
- First American Title Enhances AgentNet Platform for Agents
- Top Stocks to Consider as Political Landscapes Shift
- Fortrea Set to Reveal Third Quarter 2024 Financial Insights
- eQ Plc Set to Unveil Q3 2024 Report and Presentation Details
- Solventum's Bold Move Towards 100% Renewable Energy by 2030
- Exploring High-Yield ETFs for Income Generation and Growth
- ASMPT Privatization Approach Sparks Market Interest
- Fortrea Prepares for Third Quarter Financial Results Call
- ServiceNow Commits $1.5 Billion to Transform UK Business Landscape
- Albertsons Issues Voluntary Recall for Potential Listeria Risk
- Unicycive Therapeutics Highlights Innovations at Kidney Week 2024
- MyOme Partners with Broad Labs for Genetics Initiative
- Schouw & Co. Reports Progress on Share Buy-Back Initiative
- Unicycive Therapeutics Advances Kidney Treatments at ASN 2024
- RYVYL Inc. to Showcase Innovations at LD Micro Event
- Permira Successfully Completes Tender Offer for Squarespace
- SurplusGLOBAL Enhances Semiconductor Distribution with AI
- Kraig Labs Advances Production of Revolutionary Spider Silk
- Codexis Welcomes New Employees with Equity Grants and Awards
- Nykredit Realkredit A/S Publishes Important Prepayment Data
- Totalkredit A/S Updates on Prepayment Data and Insights
- Codexis Expands Team with New Employment Inducement Grants
- New Insights on Pidnarulex from Senhwa Biosciences' Study
- Moshe Bajnon to Steer Nuveen Private Capital's Wealth Strategy
- Dot Ai and ShoulderUp Technology Merge Ahead of Nasdaq Listing
- Poll Indicates Trump Leading Among Catholic Voters in 2024
- Market Outlook: Focus on Q3 Earnings and Economic Indicators
- Discover Butterball's Easy Cook From Frozen Turkey Option
- Longboard Pharmaceuticals Shares Surge Following Major Acquisition
- Explore Risks in Film with New Documentary 'Safe Sets'
- Gogo Business Aviation Anticipates Surge in Galileo HDX Demand
- BELFOR Franchise Group Brands Shine in Top 400 Recognition
- Rural Healthcare Transformation: Data-Driven Innovations in Practice
- Top Tips from HVAC Experts for a Cozy Winter Experience
- Alpine Income Property Trust: Recent Performance and Insights
- BD and Hamilton Revolutionize Genomic Research Automation
- Denali Therapeutics: Navigating Challenges and Future Innovations
- Mirikizumab's Groundbreaking Results in Crohn’s Disease Treatment
- Goldman Sachs Boosts Ibotta to Buy: A Strategic Move
- NCR Voyix Retains Buy Rating with $20 Price Target Amid Growth
- Impact of EU Tariffs on BYD's Electric Vehicle Strategy
- Tragic Tesla Accident in France Claims Four Lives
- Politecnico di Torino Enhances Its Impact on Space Research
- Soil Compaction Machines Market Projects Steady Growth Ahead
- KOALA AI: A Game-Changer in Cryptocurrency Listings and Community
- Ferrari N.V. Announces Significant Share Buyback Progress
- Auddia Achieves Impressive User Retention While Focusing on Growth